News

In a world grappling with urgent health threats, these youth advocates are offering bold solutions and renewed hope for the future.
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
Paul Brett’s lab leads pioneering work in melioidosis research, diagnostics and vaccine development through cross-continental collaboration ...
While the Covid-19 pandemic is firmly in the past for many Americans, US households continue to bear the costs of ...
HHS is rehiring hundreds of people fired from their positions at the CDC during initial government downsizing efforts earlier ...
The acquisition boosts BioNTech’s mRNA design and manufacturing capabilities, accelerating development of next-gen cancer ...
Republicans are characterizing the spending as wasteful and unnecessary, but Democrats say the rescissions are hurting the United States' standing in the world and will lead to needless deaths.
Prof. Oladapo Obafunwa took the helm at the Nigerian Institute of Medical Research (NIMR) in August 2024, charting a new ...
MAINZ and TÜBINGEN, Germany I June 12, 2025 I BioNTech SE (Nasdaq: BNTX, “BioNTech”) and CureVac N.V. (Nasdaq: CVAC, “CureVac”) today announced that they ...
A nationwide vaccine shortage has left thousands of infants unprotected against deadly diseases like polio, tuberculosis, and measles ...
Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech's next key milestone in the execution of its ...